Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Mariwil G. Wong"'
Autor:
Rasa Zarnegar, Mariwil G. Wong, Quan-Yang Duh, Hajime Kanauchi, David G. Ginzinger, William C. Hyun, Orlo H. Clark, Jin-Woo Park, Margaret Lobo, Philip Cotter
Publikováno v:
Thyroid. 15:222-231
Troglitazone is a potent agonist for the peroxisome proliferator-activated receptor-gamma (PPARgamma) that is a ligand-activated transcription factor regulating cell differentiation and growth. PPARgamma may play a role in thyroid carcinogenesis sinc
Autor:
Quan-Yang Duh, Philip H.G. Ituarte, Patrick A. Treseler, Orlo H. Clark, Allan Siperstein, Alessandra D'Avanzo, J. Wu, Electron Kebebew, Mariwil G. Wong
Publikováno v:
Thyroid. 14:453-458
The use of prognostic scoring systems is important for predicting the survival of individuals with thyroid carcinoma. Relatively few studies have addressed this issue for patients with follicular thyroid cancer. The goal of this retrospective study w
Diagnostic and Prognostic Value of Fas and Telomeric-Repeat Binding Factor-1 Genes in Adrenal Tumors
Autor:
Hajime Kanauchi, Mamie Yu, Mariwil G. Wong, Quan-Yang Duh, David G. Ginzinger, Orlo H. Clark, Nobuyuki Wada
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 88:3690-3693
It is often difficult to distinguish histologically between an adrenal cortical cancer and a benign adenoma, or to predict the prognosis of patients with adrenal cortical cancers. In this investigation, we examined whether apoptosis-regulating genes,
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 87:4595-4601
Hürthle cell thyroid neoplasms are classified as variants of follicular neoplasms, but they have distinct clinicopathological features. Chromosomal aberrations by comparative genomic hybridization (CGH) are common in Hürthle cell neoplasms. However
Autor:
Catharina Larsson, Orlo H. Clark, Mariwil G. Wong, Andrea Villablanca, Bin Tean Teh, Philip H.G. Ituarte, Nancy D. Perrier
Publikováno v:
World Journal of Surgery. 26:907-913
A large number of families with familial isolated hyperparathyroidism (FIHP) have been reported. We wanted to determine if some of these families represent early manifestations of full-blown syndromes such as multiple endocrine neoplasia type 1 (MEN-
Autor:
K.Jin Kim, David M. Young, Orlo H. Clark, Euy Y. Soh, Mariwil G. Wong, Monica S. Eigelberger, Quan-Yang Duh
Publikováno v:
Surgery. 128:1059-1066
Background. Without angiogenesis, tumor growth is limited to a few millimeters, the limit of diffusion. Vascular endothelial growth factor (VEGF) is an endothelial-specific mitogen and a major regulator of angiogenesis. Methods. To investigate the re
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 84:2840-2847
There is increasing evidence that phenylacetate inhibits growth and modulates differentiation in a variety of tumors with effects on gene expression, and protein prenylation and glycosylation at concentrations that have been safely used in humans. We
Autor:
Mariwil G. Wong, Quan-Yang Duh, Orlo H. Clark, Euy Y. Soh, Saif S. Al-Sobhi, Allan Siperstein
Publikováno v:
World Journal of Surgery. 22:552-557
Because some papillary thyroid cancers continue to grow when thyroid-stimulating hormone (TSH) levels are suppressed, we questioned whether desensitization (i.e., a decreased cAMP response to repeat stimulation with TSH) occurs in normal and neoplast
Autor:
Mariwil G. Wong, Richard F. Grossman, Y K Garcia, Howard D. Epstein, Orlo H. Clark, Euy Young Soh, S A Sobhi, Allan Siperstein, Quan-Yang Duh, D M Young, Y D Min
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 82:3741-3747
Vascular endothelial growth factor (VEGF) is an angiogenic factor, and its expression has been rarely demonstrated in thyroid tumors. We, therefore, investigated the expression of VEGF messenger RNA (mRNA) and production of VEGF protein in cell lines
Autor:
Quan-Yang Duh, Orlo H. Clark, Mariwil G. Wong, Andreas Zielke, Allan Siperstein, Matthias Rothmund
Publikováno v:
Journal of Surgical Oncology. 66:11-18
Background Suramin inhibits growth of neural crest-derived cells and is used to treat adrenocortical cancer and neuroblastoma in clinical trials. The antiproliferative effect of suramin was evaluated in primary cultures of human pheochromocytoma and